reports
Announcement Regarding Fossil Group Plan Meeting to Be Held on Thursda...
Announcement Regarding Fossil Group Plan Meeting to Be Held on Thursday, November 6, 2025 RICHARDSON, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Fossil (UK) Global Services Ltd (the “Plan Company”), a subsidiary of Fossil Group, Inc. (NASDAQ: FOSL) (the “Company”), announced on October 16, 2025 that pursuant to an order made by the High Court of Justice of England and Wales (the “Court”), dated October 15, 2025 (the “Convening Order”), in respect of the Company’s US $150,000,000 7.00% Senior Notes due November 30, 2026 (the “Notes”), a single meeting (the “Plan Meeting”) of such persons who...
Gouverneur Bancorp, Inc. Announces Fiscal 2025 Fourth Quarter and Fisc...
Gouverneur Bancorp, Inc. Announces Fiscal 2025 Fourth Quarter and Fiscal Year Results GOUVERNEUR, N.Y., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Gouverneur Bancorp, Inc. (OTCQB: GOVB) (the “Company”), the holding company for Gouverneur Savings and Loan Association (the “Bank”), today announced the Company’s results for the fourth quarter and full fiscal year ended September 30, 2025. The Company reported net income of $238,000, or $0.24 per basic and diluted share, for the quarter ended September 30, 2025, compared to net income of $136,000, or $0.13 per basic and diluted share, for the quarter...
Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Co...
Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference LEXINGTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Stifel 2025 Healthcare Conference in New York, NY. Company management is scheduled to participate in a 30-minute question-and-answer session with the host analys...
Trisura Announces Timing of Third Quarter Results Release and Earnings...
Trisura Announces Timing of Third Quarter Results Release and Earnings Conference Call TORONTO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurer, announces the timing of third quarter 2025 results and earnings conference call. Trisura will release its third quarter 2025 results after market close on Thursday, November 6th, 2025. The company will host a conference call for analysts and investors on Friday, November 7th, 2025 at 9:00 a.m. ET. Conference call participants will be David Clare, President and Chief Exec...
Corbus Pharmaceuticals Announces Proposed Public Offering
Corbus Pharmaceuticals Announces Proposed Public Offering NORWOOD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), an oncology and obesity company, today announced that it plans to offer and sell shares of its common stock or, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock in an underwritten registered public offering. All of the securities in the offering are to be sold by Corbus. The offering is subject to market conditions, and there can be no assurance a...
Riot Platforms Reports Third Quarter 2025 Financial Results and Strate...
Riot Platforms Reports Third Quarter 2025 Financial Results and Strategic Highlights Record quarterly revenue of $180.2 millionNet income of $104.5 million, or $0.26 diluted EPSAdjusted EBITDA of $197.2 millionAnnounces initiation of 112 MW of core and shell for data center campus CASTLE ROCK, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, reported financial results for the three-month period ended September 30, 2025. Th...
Bank of the James Announces CFO–CIO Transition and Appointment of New ...
Bank of the James Announces CFO–CIO Transition and Appointment of New Chief Financial Officer LYNCHBURG, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bank of the James Financial Group, Inc. (the “Company”) (NASDAQ:BOTJ), the parent company of Bank of the James (the “Bank”), a full-service commercial and retail bank, and Pettyjohn, Wood & White, Inc. (“PWW”), an SEC-registered investment advisor, today announced changes to the Bank’s executive leadership to improve oversight and better coordinate financial and investment approaches. J. Todd Scruggs, currently serving as Chief Financial Officer,...
Bank of the James Announces Third Quarter, First Nine Months of 2025 F...
Bank of the James Announces Third Quarter, First Nine Months of 2025 Financial Results Bank of the James Reports Record Quarterly Earnings and Margin ExpansionLoan Growth, Stable Funding Costs, and Exceptional Asset Quality Drive Record Profitability LYNCHBURG, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bank of the James Financial Group, Inc. (the “Company”) (NASDAQ:BOTJ), the parent company of Bank of the James (the “Bank”), a full-service commercial and retail bank, and Pettyjohn, Wood & White, Inc. (“PWW”), an SEC-registered investment advisor, today announced unaudited results of o...
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board ...
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors Châtillon, France, October 30, 2025 DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stage biopharmaceutical company, today announced the provisional appointment of a new independent director, Dr. Philina Lee, to its Board of Directors (the “Board”), effective October 30, 2025. Dr. Lee is appointed in replacement of Daniel Soland, subject to the ratification by...
DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein d...
DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Conseil d’administration Châtillon, France, 30 octobre 2025 DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Conseil d’administration DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (la « Société » ou « DBV »), une société biopharmaceutique au stade clinique, a annoncé ce jour la nomination provisoire d’une nouvelle administratrice indépendante, le Docteur Philina Lee, au sein de son Conseil d’administration (le « Conseil »), effective à compter du 30 octob...
CN to Report Third-Quarter 2025 Financial and Operating Results Tomorr...
CN to Report Third-Quarter 2025 Financial and Operating Results Tomorrow MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) will issue its third-quarter 2025 financial and operating results at 7:30 a.m. Eastern Time on October 31, 2025. CN's senior officers will review the results and the railway's outlook in a conference call on that day starting at 8:30 a.m. Eastern Time. Tracy Robinson, CN President and Chief Executive Officer, will lead the call. Parties wishing to participate via telephone may dial 1-800-715-9871 (Canada/U.S.), or 1-647-932-3411 (Internationa...
Nano Dimension to Host Q3 2025 Financial Results Conference Call
Nano Dimension to Host Q3 2025 Financial Results Conference Call Call to Be Held Wednesday, November 19, 2025 at 4:30 PM ET WALTHAM, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM), a leader in digital manufacturing solutions, today announced it will host a conference call and webcast to discuss its Q3 2025 financial results for the period ended September 30, 2025. Conference Call Information Date: Wednesday, November 19, 2025Time: 4:30 pm ET Pre-Registration Link for Dial-In AccessParticipants can pre-register for the conference call in order to receive ...
Le CN divulguera ses résultats financiers et d’exploitation du troisiè...
Le CN divulguera ses résultats financiers et d’exploitation du troisième trimestre de 2025 demain MONTRÉAL, 30 oct. 2025 (GLOBE NEWSWIRE) -- Le CN (TSX : CNR) (NYSE : CNI) divulguera ses résultats financiers et d’exploitation du troisième trimestre de 2025 à 7 h 30, heure de l’Est, le 31 octobre 2025. Les membres de la haute direction du CN passeront en revue les résultats et discuteront des perspectives du chemin de fer au cours d’une conférence téléphonique qui débutera à 8 h 30 (HE) ce jour-là. Tracy Robinson, présidente-directrice générale du CN, animera la conférence téléphonique. ...
Twin Disc Approves a Quarterly Cash Dividend
Twin Disc Approves a Quarterly Cash Dividend MILWAUKEE, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), today announced that the Board of Directors (the "Board") approved a regular quarterly cash dividend of $0.04 per share payable on December 1, 2025, to shareholders of record at the close of business on November 17, 2025. About Twin DiscTwin Disc, Inc. designs, manufactures and sells marine and heavy-duty off-highway power transmission equipment. Products offered include marine transmissions, azimuth drives, surface drives, propellers and boat management systems, as w...
Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-0...
Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib at SABCS 2025 SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced it will present a trial-in-progress poster for the Phase 3 OPERA-02 trial at the 2025 San Antonio Breast Cancer Symposium (SABCS 2025) taking place December 9-12, 2025 in San Antonio, TX. The trial is eva...
Primary Care Physician Use of Counterpart Assistant (CA) Technology As...
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today released a w...
CPI Aerostructures Comments on Unusual Trading Activity
CPI Aerostructures Comments on Unusual Trading Activity EDGEWOOD, N.Y., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CPI Aerostructures, Inc. (“CPI Aero” or the “Company”) (NYSE American: CVU) today issued the following statement pursuant to Section 401(d) of the NYSE American Company Guide and at the request of the NYSE American, in connection with today’s unusual trading activity in the Company’s common stock: The Company has conducted internal review and inquiries and confirms that it is not aware of any material, undisclosed corporate developments that would account for the unusual trading acti...
TFI International communique ses résultats du troisième trimestre de 2...
TFI International communique ses résultats du troisième trimestre de 2025 Le bénéfice opérationnel du troisième trimestre de 153,3 M$ se compare à celui de 201,2 M$ au trimestre correspondant de l’exercice précédentLe bénéfice net du troisième trimestre de 84,7 M$ se compare à celui du troisième trimestre de 2024 de 125,9 M$, tandis que le bénéfice net ajusté1 de 99,1 M$ se compare à celui de 134,5 M$ au troisième trimestre de 2024.Au troisième trimestre, le bénéfice par action dilué (« BPA dilué ») s’est établi à 1,02 $ comparativement à 1,48 $ au troisième trimestre de 2024, tandis que le...
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences...
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will participate at the following investor conferences: TD Cowen's Immunology & Inflammation Summit (Virtual) - fireside chat on Wednesday, November 12, 2025, at 11:30 a.m. ET 2025 Jefferies Global Healthcare Conference in London - firesi...
Gaming and Leisure Properties Reports Record Third Quarter 2025 Result...
Gaming and Leisure Properties Reports Record Third Quarter 2025 Results and Updates 2025 Full Year Guidance WYOMISSING, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (“GLPI” or the “Company”) today announced financial results for the quarter ended September 30, 2025. GLPI has posted a supplemental earnings presentation, which highlights the events of the quarter, recent developments, and future considerations, that can be accessed at . Financial Highlights Three Months Ended September 30,(in millions, except per share data) 2025 2024 Total...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.